CSIMarket
 


Sangui Biotech International Inc  (SGBI)
Other Ticker:  
 
 

SGBI's Operating Income Growth by Quarter and Year

Sangui Biotech International Inc's Operating Income results by quarter and year




SGBI Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter June - -0.05 -0.04 -0.05
III Quarter March -0.02 -0.03 -0.03 -0.04
II Quarter December -0.03 -0.02 -0.04 -0.04
I Quarter September -0.02 -0.04 -0.04 -0.06
FY   -0.07 -0.14 -0.15 -0.19



SGBI Operating Income third quarter 2023 Y/Y Growth Comment
Sangui Biotech International Inc in the third quarter 2023 recorded Operating Loss of $ -0.02 millions.

According to the results reported in the third quarter 2023, Sangui Biotech International Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Sangui Biotech International Inc' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


SGBI Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY   - - - -

Financial Statements
Sangui Biotech International Inc's third quarter 2023 Operating Income $ -0.02 millions SGBI's Income Statement
Sangui Biotech International Inc's third quarter 2022 Operating Income $ -0.03 millions Quarterly SGBI's Income Statement
New: More SGBI's historic Operating Income Growth >>


SGBI Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter June - - - -
III Quarter March - - - -
II Quarter December - - - -
I Quarter September - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Sangui Biotech International Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Operating Income Comment
Even if Sangui Biotech International Inc in the III. Quarter 2023 revealed Operating Loss of $ -0.02 millions, management mentioned, that this show improvement relative to the -0.03 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Sangui Biotech International Inc achieved highest sequential Operating Income growth. While Sangui Biotech International Inc's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


SGBI's III. Quarter Q/Q Operating Income Comment
Even if Sangui Biotech International Inc in the III. Quarter 2023 admitted Operating Loss of $ -0.02 millions, some analyst mentioned, that those numbers point to slight up side relative to the -0.03 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Sangui Biotech International Inc achieved highest sequential Operating Income growth. While Sangui Biotech International Inc's Operating Income growth quarter on quarter, overall rank is .


Sangui Biotech International Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Operating Income 12 Months Ending $ -0.11 $ -0.12 $ -0.11 $ -0.14 $ -0.13
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment


Sangui Biotech International Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment


Sangui Biotech International Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
SGBI's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for SGBI's Competitors
Operating Income Growth for Sangui Biotech International Inc's Suppliers
Operating Income Growth for SGBI's Customers

You may also want to know
SGBI's Annual Growth Rates SGBI's Profitability Ratios SGBI's Asset Turnover Ratio SGBI's Dividend Growth
SGBI's Roe SGBI's Valuation Ratios SGBI's Financial Strength Ratios SGBI's Dividend Payout Ratio
SGBI's Roa SGBI's Inventory Turnover Ratio SGBI's Growth Rates SGBI's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2023
Lemaitre Vascular Inc -0.68%$ -0.681 millions
Orgenesis Inc -0.96%$ -0.958 millions
United Therapeutics Corporation-1.25%$ -1.250 millions
Cardiff Lexington Corporation-1.36%$ -1.355 millions
Utah Medical Products Inc-1.84%$ -1.835 millions
Phibro Animal Health Corporation-3.34%$ -3.340 millions
Becton Dickinson And Company-3.68%$ -3.681 millions
Iqvia Holdings Inc -4.85%$ -4.848 millions
Intuitive Surgical Inc -5.02%$ -5.023 millions
Organon and Co -5.19%$ -5.195 millions
Tenet Healthcare Corp-6.94%$ -6.944 millions
Davita Inc -7.88%$ -7.881 millions
Zoetis Inc -10.17%$ -10.165 millions
Bio techne Corp-11.32%$ -11.317 millions
Edwards Lifesciences Corporation-11.49%$ -11.486 millions
Amedisys Inc -11.64%$ -11.640 millions
Lifevantage Corp-12.38%$ -12.384 millions
Viemed Healthcare Inc -13.97%$ -13.968 millions
Biogen Inc -16.87%$ -16.866 millions
West Pharmaceutical Services Inc -18.13%$ -18.134 millions
Chemed Corporation-18.52%$ -18.523 millions
Biomx Inc -20.27%$ -20.267 millions
Integra Lifesciences Holdings Corp-21.19%$ -21.190 millions
Dariohealth Corp -21.82%$ -21.825 millions
Community Health Systems Inc -22.22%$ -22.222 millions
National Research Corporation-22.92%$ -22.920 millions
Amgen Inc -23.16%$ -23.160 millions
Pediatrix Medical Group Inc -23.18%$ -23.185 millions
3m Company-24.38%$ -24.375 millions
Avantor Inc -24.69%$ -24.691 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com